Zhuhai Rundu Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002923.SZ

Zhuhai Rundu Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2023: USD 313.78 M

Zhuhai Rundu Pharmaceutical Co., Ltd. Total Assets is USD 313.78 M for the year ending December 31, 2023, a -5.29% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Zhuhai Rundu Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2022 was USD 331.31 M, a 10.25% change year over year.
Zhuhai Rundu Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2021 was USD 300.51 M, a 29.58% change year over year.
Zhuhai Rundu Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2020 was USD 231.91 M, a 21.73% change year over year.
Zhuhai Rundu Pharmaceutical Co., Ltd. Total Assets for the year ending December 31, 2019 was USD 190.51 M, a 15.09% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

Shenzhen Stock Exchange: 002923.SZ

Zhuhai Rundu Pharmaceutical Co., Ltd.

CEO	Mr. Jie Liu
IPO Date	Jan. 5, 2018
Location	China
Headquarters	No. 6, North Airport Road
Employees	1,945
Sector	Health Care
Industries Pharmaceuticals

Description

Zhuhai Rundu Pharmaceutical Co., Ltd., a pharmaceutical company, develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, CNS, and anesthesia areas in China and internationally. It offers APIs, intermediates, FDF, and pellets, as well as formulations in the forms of capsules, tablets, and injections. The company was founded in 1997 and is headquartered in Zhuhai, China.

Key trends

Past 5 years